The Patent Finder

Alberta Health Services

17 patents currently held · Updated Nov 16, 2026
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

5
Ending by 2030
Aug 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 26, 2026
    The maintenance fee for Small Molecule Inhibitors of Polynucleotide Kinase/Phosphatase, Poly(ADP-RIBOSE) Polymerase and Uses Thereof (US 9,040,551) comes due Nov 26, 2026. Unpaid by May 26, 2027, it lapses early.
  • 1 fee due Aug 9, 2027
    The maintenance fee for Magnetic assembly and method for defining a magnetic field for an imaging volume (US 9,255,978) comes due Aug 9, 2027. Unpaid by Feb 9, 2028, it lapses early.
  • 1 fee due Oct 21, 2027
    The maintenance fee for MRI Metamaterial Liner (US 10,627,465) comes due Oct 21, 2027. Unpaid by Apr 21, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 18, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,958,528Real-Time Dose Reconstruction Using Dynamic Simulation and Image Guided Adaptive Radiotherapy
In force
 · Low confidence
In forceLow confidence
US 9,468,777Integrated external beam radiotherapy and MRI system
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,983,573Radiation Therapy System
In force
 · High confidence
In forceHigh confidence
US 9,255,978Magnetic assembly and method for defining a magnetic field for an imaging volume
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,980,564Predictive Markers for Taxane Responsiveness and Methods of Use Thereof
In force
 · High confidence
In forceHigh confidence
US 9,040,551Small Molecule Inhibitors of Polynucleotide Kinase/Phosphatase, Poly(ADP-RIBOSE) Polymerase and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 9,458,101Novel Colchicine Derivatives, Methods and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 9,456,764Reducing artefacts in MRI k-space data with simultaneous radiation beam incident on MRI collector coils
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,589,769Peripheral Tumour Treatment
In force
 · Medium confidence
In forceMedium confidence
US 11,141,606Magnetic resonance guided stereotactic radiosurgery
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 17 patents shown.
Pro members see all 17.
Pro members: see all 17 patents
Also on record, not counted in the 17: 4 patents in force now held by others · 2 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 2 abandoned · 3 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited